<- Go Home
Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Market Cap
$650.4M
Volume
80.9K
Cash and Equivalents
$12.2M
EBITDA
-$41.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$9.07
52 Week Low
$2.57
Dividend
N/A
Price / Book Value
8.44
Price / Earnings
-13.97
Price / Tangible Book Value
8.44
Enterprise Value
$591.0M
Enterprise Value / EBITDA
-14.87
Operating Income
-$42.3M
Return on Equity
61.00%
Return on Assets
-27.55
Cash and Short Term Investments
$73.1M
Debt
$13.7M
Equity
$77.1M
Revenue
N/A
Unlevered FCF
-$19.5M
Sector
Health Care Equipment and Supplies
Category
N/A